Relay Therapeutics, Inc. (RLAY)
19.01
+0.05
(+0.26%)
USD |
NASDAQ |
Oct 05, 09:54
Relay Therapeutics Price : 19.01 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 18.71 | 19.13 | 18.60 | 18.96 | 2.771M |
| Oct 01, 2026 | 18.02 | 19.08 | 17.86 | 18.49 | 2.824M |
| Sep 30, 2026 | 18.39 | 18.72 | 17.93 | 18.05 | 2.783M |
| Sep 29, 2026 | 17.65 | 18.48 | 17.52 | 18.36 | 3.589M |
| Sep 28, 2026 | 17.10 | 17.88 | 17.05 | 17.69 | 1.846M |
| Sep 25, 2026 | 17.94 | 18.01 | 17.42 | 17.47 | 2.984M |
| Sep 24, 2026 | 18.09 | 18.09 | 17.41 | 17.73 | 3.676M |
| Sep 23, 2026 | 19.15 | 19.23 | 17.22 | 18.03 | 4.708M |
| Sep 22, 2026 | 18.43 | 19.48 | 18.21 | 19.35 | 3.632M |
| Sep 21, 2026 | 19.07 | 19.17 | 18.05 | 18.19 | 3.030M |
| Sep 18, 2026 | 19.25 | 19.40 | 18.68 | 18.84 | 10.08M |
| Sep 17, 2026 | 19.45 | 19.69 | 19.06 | 19.19 | 3.096M |
| Sep 16, 2026 | 18.97 | 19.22 | 18.62 | 18.84 | 2.117M |
| Sep 15, 2026 | 19.05 | 19.09 | 18.64 | 18.97 | 2.743M |
| Sep 14, 2026 | 18.90 | 19.43 | 18.88 | 19.06 | 2.400M |
| Sep 11, 2026 | 19.17 | 19.35 | 18.68 | 18.87 | 4.164M |
| Sep 10, 2026 | 18.30 | 19.11 | 18.10 | 18.89 | 3.001M |
| Sep 09, 2026 | 18.76 | 19.18 | 18.54 | 18.66 | 6.061M |
| Sep 08, 2026 | 18.78 | 19.28 | 18.31 | 19.11 | 5.030M |
| Sep 04, 2026 | 18.85 | 19.26 | 18.68 | 19.04 | 2.055M |
| Sep 03, 2026 | 18.55 | 19.10 | 18.34 | 19.01 | 2.717M |
| Sep 02, 2026 | 18.70 | 19.27 | 18.29 | 18.51 | 2.108M |
| Sep 01, 2026 | 18.15 | 18.68 | 17.96 | 18.49 | 1.598M |
| Aug 31, 2026 | 18.54 | 18.64 | 18.03 | 18.38 | 3.785M |
| Aug 28, 2026 | 19.15 | 19.30 | 18.63 | 18.77 | 2.763M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| SELLAS Life Sciences Group, Inc. | 11.68 |
| Karyopharm Therapeutics, Inc. | 0.7946 |
| Spyre Therapeutics, Inc. | 92.42 |
| Akebia Therapeutics, Inc. | 0.861 |
| ACADIA Pharmaceuticals, Inc. | 19.88 |
Price Related Metrics
| PS Ratio | 334.51 |
| Price to Book Value | 4.668 |
| Earnings Yield | -8.24% |
| Market Cap | 4.154B |